Scabies with Secondary Infection in Down Syndrome : A Case Report

Authors

  • Mitha Yunda Pertiwi Fakultas Kedokteran Universitas Mataram
  • Dedianto Hidajat

DOI:

https://doi.org/10.29303/jku.v10i4.625

Keywords:

clinical scabies, pruritus, secondary infection, family approach, down syndrome

Abstract

Scabies is a skin disease caused by Sarcoptes scabiei. The signs and symptoms of scabies such as pruritus and skin lesions in the form of small papules with canaliculus and escoriations. If it’s not treated, complications may occur. The most common complication is secondary infection. The principles in the management of scabies are eradicating mites with pharmacological therapy, preventing the spread of scabies, and overcoming complications. A 1-year-7-month-old child with down syndrome was consulted to the dermatovenereology clinic of RSUDP NTB with complaints of lesion since 1 month ago in the buttocks, genital, between the toes and soles, between the fingers and palms, and around the chest. The patient scratches the spots at night. The patient’s father, mother and brother experiencing similar complaints. Localized status of skin lesions are on the buttocks, external genitalia, thorax, between the fingers and toes, as well as the palms of the hands and feet. The description of lesions were papules with grayish white canaliculus, well-defined, lenticular shape, multiple, discrete arrangement, and regional distribution with scales. In addition, there are white pustules, well-defined, miliary shape, multiple, discrete arrangement, and regional distribution with crusts. The diagnosis of this patient was clinical scabies with secondary infection. The patient was given causative, symptomatic and secondary infection therapy. In addition, to treat patients, the family approach has an important role in eradicating scabies.

References

1. Gawkrodger DJ, Ardern-Jones MR. Dermatology An Illustrated Colour Text fifth edition. Churcill Livingstone; 2012. 62–63 p.
2. Engelman D, Yoshizumi J, Hay RJ, Osti M, Micali G, Norton S, Walton S, Boralevi F, Bernigaud C, Bowen AC, Chang AY, Chosidow O, Estrada-Chavez G, Feldmeier H, Ishii N, Lacarrubba F, Mahé A, Maurer T, Mahdi MMA, Murdoch ME, Pariser D, Nair PA, Rehmus W, Romani L, Tilakaratne D, Tuicakau M, Walker SL, Wanat KA, Whitfeld MJ, Yotsu RR, Steer AC, Fuller LC. The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies. Br J Dermatol. 2020;183(5):808–20.
3. Golant AK, Levitt JO. Scabies: A review of diagnosis and management based on mite biology. Pediatr Rev. 2012;33(1).
4. Sanei-Dehkordi A, Soleimani-Ahmadi M, Zare M, Jaberhashemi SA. Risk factors associated with scabies infestation among primary schoolchildren in a low socio-economic area in southeast of Iran. BMC Pediatr. 2021;21(1):1–10.
5. Karthikeyan K, Murugaiyan R, Sengottian K. Crusted scabies presenting as palmoplantar psoriasis in Down?s syndrome. Indian Dermatol Online J. 2015;6(2):140.
6. Gupta NA, Kabra M. Diagnosis and Management of Down Syndrome. Indian J Pediatr. 2014;6:560–7.
7. Lee K, Heresi G, Al Hammoud R. Norwegian Scabies in a Patient with Down Syndrome. J Pediatr [Internet]. 2019;209:253-253.e1. Available from: https://doi.org/10.1016/j.jpeds.2019.01.057
8. Wheat CM, Burkhart CN, Burkhart CG, Cohen BA. Scabies, Other Mites, and Pediculosis. In: Kang S, Amagai M, Bruckner A, Enk AH, Margolis, David J, McMichael AJ, Orringer JS, editors. Fitzpatrick’s Dermatology 9th edition. New York: Me Graw Hill Education; 2019. p. 3274–7.
9. Thompson R, Westbury S, Slape D. Paediatrics: How to manage scabies. Drugs Context. 2021;10:1–13.
10. Banerji A. Scabies. Paediatr Child Heal. 2015;20:395–7.
11. Thrap M. Antihistamines. In: Kang S, Amagai M, Bruckner A, Enk AH, Margolis, David J, McMichael AJ, Orringer JS, editors. Fitzpatrick’s Dermatology 9th edition. New York: Me Graw Hill Education; 2019. p. 3451–2462.
12. Caplan A, Fett N, Werth V. Glucocorticoids. In: Kang S, Amagai M, Bruckner A, Enk AH, Margolis, David J, McMichael AJ, Orringer JS, editors. Fitzpatrick’s Dermatology 9th edition. New York: Me Graw Hill Education; 2019. p. 3383–94.
13. Condon SC, Isada CM, Tomecki KJ. Systemic and Topical Antibiotics. In: Kang S, Amagai M, Bruckner A, Enk AH, Margolis, David J, McMichael AJ, Orringer JS, editors. Fitzpatrick’s Dermatology 9th edition. New York: Me Graw Hill Education; 2019. p. 3405–22.
14. Wang CH, Lee SC, Huang SS, Kao YC, See LC, Yang SH. Risk factors for scabies in Taiwan. J Microbiol Immunol Infect [Internet]. 2012;45(4):276–80. Available from: http://dx.doi.org/10.1016/j.jmii.2011.12.003

Downloads

Published

2022-01-22

How to Cite

Mitha Yunda Pertiwi, & Dedianto Hidajat. (2022). Scabies with Secondary Infection in Down Syndrome : A Case Report. Jurnal Kedokteran, 10(4), 655–660. https://doi.org/10.29303/jku.v10i4.625

Issue

Section

Case Report